Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.00225
Abstract: Intertumoral heterogeneity among actionable biomarkers including ERBB2, FGFR2 and EGFR has been observed to occur under therapeutic pressure in advanced gastric cancer. However, baseline intratumoral heterogeneity at diagnosis is understudied and may impact clinical outcomes.…
read more here.
Keywords:
gastric cancers;
heterogeneity;
heterogeneity primary;
intratumoral heterogeneity ... See more keywords